Media Summary: Complete vs. Lesion-only PRimary-PCI Trial (CvLPRIT): Treat only the infarct-related artery or all lesions? Effect of intravenous TRO40303 as an adjunct to PCI for acute STEMI: Results of the MITOCARE Study. FOCUS: Fixed-dose combination drug for secondary cardiovascular prevention.
Ehj Today Esc Myocardial Revascularization Guidelines - Detailed Analysis & Overview
Complete vs. Lesion-only PRimary-PCI Trial (CvLPRIT): Treat only the infarct-related artery or all lesions? Effect of intravenous TRO40303 as an adjunct to PCI for acute STEMI: Results of the MITOCARE Study. FOCUS: Fixed-dose combination drug for secondary cardiovascular prevention. Plaque statbilition using Darapladib -Thrombolysis in Interviewee : Prof. Stephan Windecker, FESC, Bern, Switzerland Interviewer : Liam Davenport,
